bioMerieux, Inc logo

bioMerieux, Inc

Pioneering Diagnostics A world leader in the field of in vitro diagnostics for 60 years, bioMérieux is present in 45 countries and serves more than 160 countries with the support of a large network of distributors. In 2020, revenues reached €3.1 billion, with over 90% of sales outside of France. bioMérieux provides diagnostic solutions (systems, reagents, software, services) which determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are mainly used for diagnosing infectious diseases. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products. bioMérieux is listed on the Euronext Paris stock market. Symbol: BIM – ISIN Code: FR0013280286 Reuters: BIOX.PA/Bloomberg: BIM.FP

Free account • No credit card • 5 profiles/day

Biotechnology Research 13,107 Employees Found Basingstoke, United Kingdom Founded 1963 10 Similar Companies
13,107 Employees Found
94% Email Coverage
$3.8B Est Revenue
+1% YoY Headcount Growth
61 Office HQ
10 Similar Companies
Sep '26 Last Verified

bioMerieux, Inc – Company Information

Biotechnology Research
Founded 1963
100, Allée Louis Pasteur, Marcy-l'Étoile, Auvergne-Rhône-Alpes, 69280, FR
pharmaceutical molecular biology cosmetics sepsis microbiology food safety in vitro diagnostics infectious diseases industries immunoassays reagents rapid diagnostics medical analysis antimicrobial stewardship healthcare associated infections automated instruments blood bank veterinary diagnostics
WordPress React GitHub Microsoft Azure Slack Python Salesforce Drupal SAP JIRA Oracle Docker
Jul 2026
bioMérieux to Showcase Company's Latest in Diagnostic Innovations at ADLM 2026

bioMérieux highlighted its advanced diagnostic solutions at the annual ADLM meeting in Anaheim.

Jul 2026
bioMérieux Launches Rapid PCR Test for Probiotic Species Verification in Dietary Supplements

The company introduced a new assay to help quality control teams identify commonly used probiotic strains.

Jun 2026
bioMérieux Launches RT-PCR Salmonella Assay to Support Food Industry Root Cause Analysis

A new real-time PCR assay was released to aid food safety professionals in rapid root cause investigations.

Find bioMerieux, Inc contacts

Decision Makers by Function

Vee Arya

Vee Arya

Director

Associate Director Quality Assurance • Influencer • 3 years

View
Michael Reynier

Michael Reynier

Director

Senior Vice President, Pharma Quality Control Business • Influencer • 11 years

View

Maria Fernanda Areal

Director

Associate Director Food Safety & Quality Business, LatAm • Influencer • 1 year

View

Iman Nachaat

CFO Africa & METER (Middle East, Turkey, Export Markets & Russia) • Influencer • 4 months

View
Yasha Mitrotti

Yasha Mitrotti

VP

Executive Vice President Industrial Applications • Champion • 6 years

View
Arnaud Paris

Arnaud Paris

IBERIA Cluster Head - Industrial Applications • Influencer • 1 year

View
Cesar Roman

Cesar Roman

Head

Commercial Excellence Head, Latin America • Champion • 1 year

View
Rajesh Sharma Rrcp

Rajesh Sharma Rrcp

Director

National Healthcare Business Development Manager - Clinical • Influencer • 4 months

View
Alex Cherlin

Alex Cherlin

Director

Regional Sales Director • Influencer • 4 years

View
Vanina Laurent-ledru

Vanina Laurent-ledru

Partner

Chief Public Health and Government Affairs Officer • Economic Buyer • 8 months

View
Jennifer Zinn

Jennifer Zinn

VP

Executive Vice President, Global Clinical Operations • Champion • 3 years

View
Debkishore Gupta

Debkishore Gupta

Director

Director & Head, Medical Affairs - South Asia • Influencer • 3 years

View

Frequently asked questions about bioMerieux, Inc

What is bioMerieux, Inc email format?

The widely used bioMerieux, Inc email format is {first}.{last} (e.g. john.smith@biomerieux.com) with 81.53% adoption across the company.

What is bioMerieux, Inc customer service number?

To contact bioMerieux, Inc customer service number in your country click here to find.

Who is the CEO of bioMerieux, Inc?

Marc Mackowiak is the CEO of bioMerieux, Inc.

Who are the decision makers in bioMerieux, Inc?

The decision makers in bioMerieux, Inc are Marc Mackowiak, Eric Bouvier, etc. Click to Find bioMerieux, Inc decision makers emails.